Publication | Closed Access

Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients

Retrospective StudyReverse Transcriptase InhibitorHuman RetrovirusPharmacologyAntiviral TherapyVirologyPharmacotherapyAntiviral DrugHivMedicineTwo-drug Regimens